Threadneedle Ethical UK Equity Fund Z Accumulation GBP
|GlaxoSmithKline PLC||7.80 %|
|Prudential PLC||6.54 %|
|Unilever PLC||5.57 %|
|AstraZeneca PLC||4.29 %|
|Ascential PLC||3.97 %|
|RELX PLC||3.53 %|
|Legal & General Group PLC||3.52 %|
|Johnson Matthey PLC||3.45 %|
|Compass Group PLC||3.19 %|
|Spirax-Sarco Engineering PLC||3.06 %|
|United Kingdom||99.24 %|
|Consumer Cyclical||25.81 %|
|Financial Services||18.61 %|
|Basic materials||8.11 %|
|Consumer Defensive||6.95 %|
James Thorne joined Threadneedle in 2010 as a portfolio manager in the UK equities team. He is also responsible for stock analysis and idea generation for the wider team with research responsibility for the chemicals and technology sectors. James has extensive experience of the smaller companies sector, having worked at Baring Asset Management, Hill Samuel and Abbey Life as well as private equity company 3i. He has a BSc in Oceanography with Geology from the University of Southampton and an MSc in Instrumentation and Analytical Science from the University of Manchester.
Data provided by Morningstar.
The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Money Observer and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.
This information is sourced from our partner Morningstar. We believe the data to be correct however you should take care in using any information.
You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.